1. Home
  2. CERO vs MITQ Comparison

CERO vs MITQ Comparison

Compare CERO & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • MITQ
  • Stock Information
  • Founded
  • CERO 2017
  • MITQ N/A
  • Country
  • CERO United States
  • MITQ United States
  • Employees
  • CERO N/A
  • MITQ N/A
  • Industry
  • CERO
  • MITQ Telecommunications Equipment
  • Sector
  • CERO
  • MITQ Telecommunications
  • Exchange
  • CERO Nasdaq
  • MITQ Nasdaq
  • Market Cap
  • CERO 8.4M
  • MITQ 8.0M
  • IPO Year
  • CERO N/A
  • MITQ 2021
  • Fundamental
  • Price
  • CERO $1.92
  • MITQ $0.74
  • Analyst Decision
  • CERO
  • MITQ
  • Analyst Count
  • CERO 0
  • MITQ 0
  • Target Price
  • CERO N/A
  • MITQ N/A
  • AVG Volume (30 Days)
  • CERO 787.1K
  • MITQ 4.5M
  • Earning Date
  • CERO 02-20-2025
  • MITQ 02-18-2025
  • Dividend Yield
  • CERO N/A
  • MITQ N/A
  • EPS Growth
  • CERO N/A
  • MITQ N/A
  • EPS
  • CERO N/A
  • MITQ N/A
  • Revenue
  • CERO N/A
  • MITQ $18,756,000.00
  • Revenue This Year
  • CERO N/A
  • MITQ N/A
  • Revenue Next Year
  • CERO N/A
  • MITQ N/A
  • P/E Ratio
  • CERO N/A
  • MITQ N/A
  • Revenue Growth
  • CERO N/A
  • MITQ N/A
  • 52 Week Low
  • CERO $1.76
  • MITQ $0.42
  • 52 Week High
  • CERO $1,238.00
  • MITQ $1.55
  • Technical
  • Relative Strength Index (RSI)
  • CERO 34.43
  • MITQ 50.27
  • Support Level
  • CERO $1.76
  • MITQ $0.68
  • Resistance Level
  • CERO $3.18
  • MITQ $0.76
  • Average True Range (ATR)
  • CERO 0.38
  • MITQ 0.07
  • MACD
  • CERO 0.30
  • MITQ -0.01
  • Stochastic Oscillator
  • CERO 19.72
  • MITQ 21.39

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.

Share on Social Networks: